Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertension

  • Technology appraisal guidance
  • TA1009
  • Published: 
The timelines for this appraisal are now confirmed. The first committee meeting will be held on 12 December 2023.